Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 USD | +1.72% | +3.14% | -18.61% |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
02/06 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.61% | 83.29B | |
+42.09% | 739B | |
+32.34% | 598B | |
-5.91% | 353B | |
+17.45% | 318B | |
+3.50% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.98% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab